-
Use of POCUS to Diagnose Heart Failure
24 Oct 2021 11:32 GMT
… POCUS to Guide Diuretic Therapy in HF
Dr Neil … CXR in monitoring response to therapy.6 Similarly, Mozzini and … assess her response to therapy and titrate her diuretics … before discharge predicts rehospitalization in heart failure: A lung ultrasound study. …
-
Heart Failure Pipeline Drugs and Companies Insight Report: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments
20 Oct 2021 21:23 GMT
… Heart Failure Early Stage Products (Phase I) 9 Heart Failure Preclinical Stage Products 10 Heart Failure Therapeutics … Assessment 11 Heart Failure Inactive Products …
-
Emerging Drugs for the Heart Failure Treatment: A Focus on Recent Clinical Trials | DelveInsight
20 Oct 2021 00:00 GMT
…
Heart Failure Report Introduction
2
Heart Failure Executive Summary
3
Heart Failure Overview
4
Heart Failure Pipeline Therapeutics
5
Heart Failure Therapeutics …
-
Heart Failure Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working
19 Oct 2021 23:52 GMT
… on the current and emerging therapies.
Heart Failure market report provides a global … 11. Heart Failure Emerging Therapies 12. Heart Failure Market Outlook 13. Country-Wise Heart Failure Market Analysis …
-
Sporadic Inclusion Body Myositis (sIBM) Clinical and Non-Clinical Studies, Emerging Pipeline Therapies, Treatment Algorithm | Key Companies- Orphazyme, Novartis. Kv1.3 Therapeutics, and Others
20 Oct 2021 21:24 GMT
… Japan.
Trending Healthcare Blog
Heart Failure Market Size and Share Analysis … working to develop pharmacological therapies for Heart Failure include Boehringer Ingelheim, Eli … , and others. Read More: Heart Failure Market
About DelveInsight
DelveInsight is …
-
Rocket Pharmaceuticals Announces Positive Clinical Data from RP-L201 Trial for the Treatment of LAD-I at the 28th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
20 Oct 2021 12:55 GMT
… and sustainable pipeline of genetic therapies for rare childhood disorders, today … Lentiviral-mediated Ex-vivo Gene Therapy for Pediatric Patients with Severe … )-based gene therapy is for Danon disease, a devastating, pediatric heart failure condition …
-
Cardiol Therapeutics Expands LANCER, a Phase II/III Trial of CardiolRxTM, into Brazil, Mexico, and Canada
18 Oct 2021 17:59 GMT
… including the development of heart failure, acute myocardial infarction, … acute myocarditis and heart failure.
About Cardiol Therapeutics
Cardiol Therapeutics Inc. (NASDAQ … anti-inflammatory therapies for the treatment of chronic heart failure – …
-
Cardiac Rhythm Management Device Market- Global Size, Trends, Opportunities and Forecast 2027: Credence Research
25 Oct 2021 17:36 GMT
… , Defibrillators, and Cardiac Resynchronization Therapy (CRT) are some of … heart failure among operators. Defibrillators are the key to survival and absolute therapy … 2027
Pacemakers
Defibrillators
Cardiac Resynchronization Therapy (CRT)
Global Cardiac Rhythm …
-
Outgoing NIH director reflects on genome discoveries, COVID and what’s next
25 Oct 2021 14:11 GMT
… But also working on therapeutics developed a partnership with … ACTIV [Accelerating COVID-19 Therapeutic Interventions and Vaccines] which … process of identifying possible therapies and getting them tested … on gene therapy, and a new kind of heart failure that …
-
Antares Pharma Announces Oral Presentation at the 22nd Annual Fall Scientific Meeting of SMSNA
25 Oct 2021 14:03 GMT
… approximately 6 weeks after initiating therapy, periodically monitor for and treat … androgen indicated for testosterone replacement therapy in adult males for conditions … Edema with or without congestive heart failure may be a complication in …
About
© 1995-2021